A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Antimicrobial Peptide PL-5 Topical Spray in Patients with Mild Infections of Diabetic Foot Ulc

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Geoffrey Gurtner
Sponsor
Parexel International Corporation
Unit
Surgery